TherapeuticsMD to Host Third Quarter 2014 Financial Results Conference Call and Webcast November 6

TherapeuticsMD Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced that it will hold a conference call and live audio webcast to discuss third quarter financial and business results Thursday, November 6, 2014. The conference call and webcast will take place at 4:30 p.m. EST. Chief Executive Officer Robert G. Finizio and Chief Financial Officer Dan Cartwright will host the call.

Details for the call and webcast include:

Shortly after completion of the call and webcast, an audio replay and a webcast replay will be available for at least 30 days on the company's website, www.therapeuticsmd.com, in the “Investor” section.

About TherapeuticsMD Inc.

TherapeuticsMD Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology platform, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products that enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes three phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins and cosmetics under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.